药 物 回 收
|
| |
| Canada: Recall: SIMLANDI: Product Quality (English only) |
| |
Health Canada announces that Jamp Pharma Corporation is recalling the following adalimumab-containing products from retailers because the affected lots contain an additional excipient (phosphate buffer):
- SIMLANDI injection solution 40mg / 0.4ml (pre-filled syringe) (lot number: 1917469A)
- SIMLANDI injection solution 40mg / 0.4ml (auto-injector) (lot number: IL220019, IL220023, IL220028, IL220036, IL220037, IL220042, IL220043)
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/simlandi-product-quality
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Tuesday, Apr 18, 2023
Issued at HKT 13:00
|
| |
